sefulness of meditation in psoriasis
Not Applicable
Completed
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2022/12/047862
- Lead Sponsor
- AIIMS Mangalagiri
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
•Consecutive consenting patients of both genders aged 18-60 years, attending dermatology OPD of AIIMS Mangalagiri diagnosed with moderate to severe psoriasis
•Definition of moderate to severe psoriasis is (BSA > 10 or PASI >10) and DLQI > 10. Special clinical situations may change mild psoriasis to moderate to severe including involvement of visible areas or severe nail involvement.
Exclusion Criteria
1. Pregnant and lactating women
2. Pre-existing psychiatric illness
3. Pre-existing illnesses like hepatic and renal disease, connective tissue diseases, and malignancies
4. Disease onset within the last 3 months
5. Patients who are practicing yoga/meditation regularly in the past 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time taken to achieve PASI 75 score.(75% reduction of disease severity from baseline)Timepoint: After 4 months of intervention
- Secondary Outcome Measures
Name Time Method 1. Effectiveness of the meditation on the changes in the serum levels of interleukin 6, and serum cortisol in patients with psoriasis <br/ ><br>2. Effectiveness of the intervention on the changes in the stress scores and sleep scores.Timepoint: After 4 months of intervention